Guiding ATMPs to patients

Here you can find information on what is happening in Sweden in development of medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. We welcome your collaboration towards accelerated and effective patient solutions.

Register for ATMP Sweden 2020 in Stockholm!

Register for Sweden's premier annual ATMP conference!

Join us in Stockholm April 1-3, 2020. Sponsorship package now available! Find our more here!

Read more

Subscribe to our mailing list

Subscribe to receive our quarterly newsletter and updates on the next ATMP Sweden conference.

Follow us on LinkedIn!

Resources

Check out the ATMP map

Use our interactive map to find clinics, manufacture facilities and CAMP/Swelife-ATMP partners.

The ATMP regulatory guide

Use this guide to navigate development of your ATMP to Phase I!

What are ATMPs?

What is the difference between a transplant and a cell based ATMP?

News

Anna Pasetto receives prestigious award to fight cancer with T cells

2020-01-08

Sjöberg foundation awards 6 million over 3 years to engineering of T cells against Hepatocellular Carcinoma

Read more

BOOSTB4 trial in Osteogenesis Imperfecta is recruiting!

2020-01-08

Please spread this information to those with patients relevant to this trial.

Read more

Jobs: Manufacturing Scientist Cobra Bio

2020-01-07

Applications due 31st January, 2020.

Read more
Display all news

Events

30

March

Gene/Cell Therapy Product (ATMP) Drug Development

Course

Details

01

April

ATMP Sweden 2020

Conference

Details

01

April

Flemingsberg ATMP Network symposia

Conference

Details
Show all events

Work with us!

CAMP

Join our experts in the science and technology for GMP compliant clinical translation of ATMPs.

Swelife-ATMP

Join our experts in the knowledge, processes and competencies for getting ATMPs to patients.

ATMP Innovation Environment

Works with us towards making ‘Sweden a world leader advanced therapies by 2030’

ATMP success stories

From 'bubble babies' to cancer - How ATMPs are revolutionising medicine

There are cell and gene therapies being developed all over the world for a variety of indications. Find our more about ATMP successes here!

Read more

Other collaborating national projects

VOG Cell

VOG cell is responsible for ensuring Swedish GMP manfacturing facilities function at the highest level and are compliant with current regulations.

AdBIOPRO

AdBIOPRO is developing Continuous Processing of emerging potent therapeutic products such as recombinant viral vector and cell Products.

Future Medicine

This Group will be developing a long term strategy for the future of the ATMP field in Sweden. The Project will ensure that all necessary networks and stakeholders are involved.

See all ATMP relevant organisations here